Healthcare -
Biotechnology - NASDAQ - US
$ 3.69
2.5 %
$ 39.8 M
Market Cap
-2.07
P/E
LTRN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LTRN - Lantern Pharma Inc.
-500 K
LAST VALUE
-0.39%
2 YEAR CAGR
-14.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR